Login / Signup

Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death.

Sook-Kyoung HeoEui-Kyu NohHo-Min YuDo Kyoung KimHye Jin SeoYoo Jin LeeJaekyung CheonSu Jin KohYoung Joo MinYunsuk ChoiJae-Cheol Jo
Published in: BMC cancer (2020)
Therefore, our results can be concluded that radotinib in combination with Ara-C possesses a strong anti-AML activity.
Keyphrases
  • acute myeloid leukemia
  • cell death
  • allogeneic hematopoietic stem cell transplantation
  • high glucose
  • diabetic rats
  • drug induced
  • endothelial cells